Janssen Search
Search results
Johnson & Johnson highlights innovation in hemolytic disease of the fetus and newborn (HDFN) at the Society for Maternal-Fetal Medicine’s (SMFM) 2024 Pregnancy Meeting
Feb 09, 2024 United States Presentations include additional analyses of nipocalimab data from pregnancies at risk for early-onset severe HDFN; Nipocalimab is the only anti-FcRn being studied in this rare and potentially life-threatening two-person disease ...
Vaccines: The Heroes of Public Health
Vaccines: The Heroes of Public Health This year’s World Immunization Week, themed, ‘ Protected Together: Vaccines Work! ’ celebrates ‘Vaccine Heroes’ from around the world. It gives us a moment to consider the significant leaps forward we have made as a ...
Strength in Numbers: How Data Science is Unlocking Innovation, and Transforming the Way We Prevent, Treat and Cure Disease
Strength in Numbers: How Data Science is Unlocking Innovation, and Transforming the Way We Prevent, Treat and Cure Disease When most people hear the term 'data science,' they probably think of people sitting at their laptops feverishly ...
Global Public Health Leaders
JANSSEN LEADERSHIP IN GLOBAL PUBLIC HEALTH At Janssen, we have a single overarching mission: to address and solve the most important unmet medical needs of our time. Our commitment to global public health is an important contribution toward achieving ...
Sharing Our Learnings
Sharing Our Learnings It is our mission to share key learnings on how to objectively, fairly and ethically approach compassionate use requests and advance public health. CompAC is a model that has the potential for wider application within the industry. ...
JCI Initiatives
JCI Initiatives Sep 02, 2020 Subhead: Lorem ipsum dolor sit amet, consectetuer adipiscing elit By combining the agility of a lean team, the resources and industry-leading position of Janssen, and the expertise and reach of innovative collaborators, JCI ...
Thinking Differently about Health Care: A Finnish Formula for Collaboration
Thinking Differently about Health Care: A Finnish Formula for Collaboration In our ever-evolving health care landscape, where patients’ desire for improved health and researchers’ ability to innovate grow in tandem, the medical industry is becoming more ...
The Power of Precision Medicine for Patients
The Power of Precision: How J&J is Working to Deliver the Promise of Precision Medicine to Patients with Complex Disease DNA Day on April 25 is an annual, global celebration of the discovery of the double helix structure of deoxyribonucleic acid ...
Joining Forces with CEPI To Address Epidemic Threat
Joining Forces with CEPI To Address Epidemic Threat Two years ago, in January 2017, the Janssen Pharmaceutical Companies of Johnson & Johnson was proud to support the launch of the Coalition for Epidemic Preparedness Innovations (CEPI) at the World ...
Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.
YUSRI A. ELSAYED, M.D., M.H.Sc., Ph.D. SENIOR VICE PRESIDENT GLOBAL ONCOLOGY THERAPEUTIC AREA HEAD As Global Oncology Therapeutic Area Head for Johnson & Johnson, Yusri Elsayed, M.D., M.H.SC, Ph.D. is responsible for the discovery, development and ...